Butamirate citrate
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162613This classification denotes an antitussive agent with the molecular formula C18H29NO3.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67HP51L98R, chemically known as butyric acid, 2-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, citrate but more generally known as butamirate citrate, which bears US NIH Compound Identifier 28891. European Medicines Agency schedules Butamirate citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00911MIG. Most nations, for tariff and trade purposes, schedule butamirate citrate under HS 29221980 and SITC 51461. As of Q4 2014, BUTAMIRATE CITRATE remains US FDA's Preferred Term for this commodity. SMILES: CCC(C1CCCCC1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.